Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, ...
Long before winter seals the forest under ice, certain frogs begin preparing for a transformation that defies basic biology.
Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...